CompletedPhase 3NCT04979884

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Alexandria University
Principal Investigator
Maged El-Setouhy
Alexandria University
Intervention
cyclosporine(drug)
Enrollment
66 enrolled
Eligibility
18-65 years · All sexes
Timeline
20222022

Study locations (1)

Collaborators

Science and Technology Development Fund (STDF), ,Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04979884 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials